The crucial role of herpes simplex virus type 1 immediate early protein Vmw175 (ICP4) in the regulation of all classes of viral genes has been established by extensive analysis of temperaturesensitive, insertion and deletion mutants. It has long been known that Vmw175 binds to selected DNA sequences, and recent studies have shown that it interacts with components of the basal transcription machinery. However, the role of DNA binding in its mechanism of action has been controversial. Despite the presence of Vmw175 recognition sites at numerous locations throughout the viral genome, it has proved difficult to establish that these sites are
Introduction
The genes of herpes simplex virus type 1 (HSV-1) are classified as immediate early (IE), early or late on the basis of the time-course and drug sensitivity of their expression, and this temporally regulated cascade is controlled by viral and cellular transacting polypeptides (for reviews see Fields et al., 1996) . The IE polypeptide Vmw175 is a potent transactivator which is essential for the activation of later classes of viral genes, and it is required continuously throughout infection (Preston, 1979 ; Watson & Clements, 1980 ; DeLuca et al., 1985) . Loss of Vmw175 function also results in high levels of expression of all IE genes.
Early studies with Vmw175 demonstrated that it is a sequence-specific DNA binding protein, and examination of a number of binding sites led to the description of a consensus recognition element Beard et al., 1986 ; Muller, 1987) . Additional experiments illustrated that Vmw175 binds to diverse sequences at multiple locations throughout the viral genome (Michael et al., 1988 ; important for the activation of early and late promoters. In this study we have analysed the ability of a large number of insertion and single point mutant derivatives of Vmw175 to bind to DNA and to support virus replication. Vmw175 mutants which were unable to bind to DNA were also incapacitated in terms of their ability to activate gene expression in transfection assays and to complement the growth of a Vmw175 deletion mutant virus. These results strongly support the hypothesis that interaction with DNA is an essential feature of the mechanism of action of Vmw175.
1989 ; Imbalzano et al., 1990 ; Papavassilliou & Silverstein, 1990) , but a statistical analysis showed that most of the apparently divergent recognition sites conformed to a more loosely defined consensus sequence (DiDonato et al., 1991) . Indeed, a detailed functional analysis showed that, within an approximate tenfold range of binding affinity, Vmw175 could tolerate single base changes at many positions within the original consensus sequence .
However, the role of these binding sites in the mechanism of action of Vmw175 remains elusive. Extensive mutational analysis of promoters responsive to Vmw175, in both transfection experiments and in the context of the viral genome, has revealed only one example of a specific binding site which is apparently required for activation by Vmw175 in vivo (Everett, 1984 ; Coen et al., 1986 ; Smiley et al., 1992 ; Romanelli et al., 1992) . It is possible that the frequency of binding sites within the genome leads to functional redundancy, so that elimination of any one individual site will have a negligible effect on transactivation by Vmw175. Alternatively, DNA binding by Vmw175 may not be obligatory to its mechanism of action.
The DNA binding domain of Vmw175 has been located within residues 276-490 of the 1298 residue protein (Wu & Wilcox, 1990 ; Everett et al., 1991) , and several previously published functional studies using deletion and insertion mutants have indicated that Vmw175 requires the ability to bind to DNA in order to be functional (DeLuca & Schaffer, 1988 ; Paterson & Everett, 1988 a, b ; Shepard et al., 1989) . However, one Vmw175 mutant, pri12, supports HSV-1 replication whilst apparently having greatly reduced in vitro binding to a specific recognition sequence . Taken with the difficulty of demonstrating a clear requirement for Vmw175 recognition sequences in transcriptional activation, this result calls into question the contribution of the specific DNA binding activity of Vmw175 to its transactivation function.
The aim of the experiments described in this paper was to conduct a thorough mutational analysis of a particularly highly conserved region (residues 445-476) within the Vmw175 DNA binding domain in order to examine the affects of single amino acid changes on the ability of Vmw175 to bind to DNA, to activate transcription and to support virus growth. The results indicate that the integrity of the DNA binding domain is essential for Vmw175 activity in all three assays, thus strongly supporting the hypothesis that DNA binding plays a crucial role in Vmw175 function.
Methods
Plasmids and bacteria. Plasmids pT7I9, pT7I9X, pT7I10 and pT7I10X, which express variations of the DNA binding domain of Vmw175 from the p585.4 vector (based on pET8c), have been described previously Pizer et al., 1991) . Plasmids were constructed and maintained in E. coli strain DH5 and expression was induced in strain BL21(DE3)pLysS (Studier et al., 1990) . Plasmids p175 and pI9-pI20, which express the wild-type and mutant forms of Vmw175 driven by the SV40 enhancer, have been described previously (Paterson & Everett, 1988 a, b) .
The pGL plasmids, which contain various point and deletion mutations within the IE-3 open reading frame (ORF) carried on plasmid p175, were constructed as follows. Site directed mutagenesis was used to remove the BamHI restriction site situated at nucleotide 1725 within the IE-3 ORF of plasmid pI11, using the mutagenic oligonucleotide 5h GCCTCCAGGATGCCGCGGCA 3h to give plasmid pGL11. This operation removed the BamHI site to ease later cloning operations, while maintaining the coding potential of the plasmid. The Nru I-BamHI restriction fragments encompassing nucleotides 920-1568 of the IE-3 ORF containing various mutations, as described in the text, were ligated to the small Pst I-Nru I fragment from plasmid p175, which includes the 5h portion of the IE-3 ORF, and the large BamHI-Pst I fragment from the plasmid pGL11, which carries the 3h portion of the IE-3 ORF (including the mutated BamHI restriction site). Plasmid pLI175 contains the wildtype IE-3 coding region with the mutation within the BamHI restriction site at nucleotide 1725.
Mutagenesis of the DNA binding domain of Vmw175. The
EcoRI-BamHI fragments of plasmids pT7I9 and pT7I10, which encode Vmw175 residues 252-523 and 276-523 respectively, were cloned into M13mp18 and the resultant M13T7I9 and M13T7I10 constructs were used for site-directed mutagenesis. Four overlapping oligonucleotides (LA15-18) complementary to the region spanning codons 445-476 of the IE-3 reading frame were used for mutagenesis (see Fig. 1 b) . Oligonucleotides were synthesized using a C precursor mix which had been contaminated with the A phosphoramidite at a ratio expected to produce one random C to A mutation per oligonucleotide molecule. Mutagenesis was carried out using the Amersham site-directed mutagenesis system, following the manufacturer's instructions. Mutant clones were identified by dideoxy sequence analysis.
EcoRI-BamHI restriction fragments containing the desired mutations were isolated from mutant phage replicative forms and cloned into the pT7I9 or pT7I10 vectors. An oligonucleotide containing stop codons in all three reading frames was inserted into the 3h BamHI site to create mutant pT7I9X or pT7I10X vectors. The identity of all clones was confirmed by restriction enzyme analysis and by direct sequencing of the plasmid DNA.
Expression and purification of DNA binding domain peptides. Plasmids expressing wild-type and mutant forms of the I10X polypeptide were transfected into BL21(DE3)pLysS bacteria. Growth of these bacteria, induction of expression, preparation of crude extracts and partial purification were essentially as described previously . Minor modifications included the occasional use of high-speed centrifugation (40 000 r.p.m., Sorvall Ti50 rotor) in the presence of 2 M NaCl (instead of sonication and treatment with DNaseI and polyethylenimine) to remove nucleic acid from the crude lysates, and the use of ammonium sulphate at 30 % saturation to precipitate the DNA binding domain polypeptides. These variations were found to improve the yield of some of the mutant polypeptides. The polypeptide contents of the final soluble extracts were determined by SDS-PAGE and Western blot analysis.
Purification of DNA binding domain polypeptides by FPLC.
Selected polypeptides were further purified by FPLC to enable analysis by gel filtration chromatography. Partially purified extracts were applied to a Pharmacia MonoS column and proteins eluted by a salt gradient as described previously . Fractions containing DNA binding domain peptides were identified by SDS-PAGE. Where necessary, they were concentrated using Amicon Centricon 10 concentrators before further analysis.
Analytical gel filtration chromatography. The dimerization state of selected polypeptides was determined by gel filtration using Pharmacia Superose 12 or Superdex 75 columns as described previously , except that the buffer used was 50 mM HEPES pH 7n5, 0n5 M NaCl, 0n01 % CHAPS, 1 mM PMSF, 0n1 mM DTT. Fractions containing DNA binding domain polypeptides were identified by SDS-PAGE and Western blotting.
SDS-PAGE and Western blotting.
Bacterial extracts, partially purified DNA binding domain polypeptides and nuclear extracts from transfected HeLa cells were analysed by SDS-PAGE using a Bio-Rad Miniprotean II kit as recommended by the supplier. Western blotting was accomplished in the compatible Bio-Rad kit. Bacterially expressed Vmw175 DNA binding domain polypeptides were detected using a rabbit polyclonal antibody directed against the DNA binding domain of Vmw175 (Everett et al., 1993) and intact Vmw175 expressed in transfected cells was detected using monoclonal antibody 58S (Showalter et al., 1981) and the HRP or Amersham ECL detection system.
DNA binding analysis.
Gel retardation analysis using probes spanning the IE-3 cap site (which contains a strong Vmw175 binding site) was conducted as described previously using appropriate amounts of partially purified bacterially expressed Vmw175 DNA binding domain polypeptides or nuclear extracts prepared from transfected HeLa cells by the method of Dignam et al. (1983) . Cheung, 1989 ; Grundy et al., 1989) . HSV-1 Vmw175 residues 442-485 are shown with asterisks indicating the completely conserved residues. The F signs indicate those residues that have been mutated in this study. (b) The coding and amino acid sequences of the highly conserved part of the Vmw175 DNA binding domain near the C terminus of region 2. The positions of the oligonucleotides that were used for mutagenesis are indicated. newborn calf serum ; HeLa cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 2n5 % newborn and 2n5% foetal calf sera. RR1 cells, which express Vmw175 from the cellular genome, were grown in DMEM supplemented with 10 % foetal calf serum ; G418, final concentration 400 µg\ml, was included in alternate passages to select for the presence of the integrated IE-3 gene. The wildtype virus used in this study was HSV-1 strain 17. Derivative D30EBA, which contains a deletion of nucleotides 246-3806 within both copies of the IE-3 gene , was propagated and titrated on RR1 cells.
Cells and viruses. Baby hamster kidney cells (BHK
Transfections and CAT assays. HeLa cells in 50 mm dishes were transfected by the calcium phosphate co-precipitation technique, and cell extracts were prepared for assay of chloramphenicol acetyltransferase (CAT) activity as previously described . Each experiment used 4 µg of indicator plasmid pgDCAT, 4 µg of the Vmw110 expression plasmid p111 and increasing amounts of the activator plasmids, ranging from 0n05 to 4 µg. The total amount of DNA in the transfection mixture was kept constant with pUC9. The titration transfection experiments were independently repeated on at least four occasions. Expression of intact Vmw175 for DNA binding analysis was conducted using HeLa cells in 90 mm dishes transfected by the calcium phosphate method with 10 µg of the expression plasmid.
Construction of recombinant viruses. A mixture containing approximately 1 µg of plasmid p175 or mutant derivative (linearized with PstI), 3 µg of D30EBA viral DNA and 5 µg of calf thymus DNA (as a carrier) were transfected into 2i10' BHK cells as previously described . Following transfection, cells were incubated at 37 mC or 31 mC for 3-4 days. The cells and medium from each plate were harvested, sonicated and stored as a virus stock. The titres of viable recombinant viruses were determined by titration on BHK cells at 37 mC or 31 mC as indicated in the text.
Results

Mutagenesis of a highly conserved tract within the Vmw175 DNA binding domain
The DNA binding domain of Vmw175 is contained within residues 276-490, a segment which can be expressed in E. coli as a soluble, stable and dimeric polypeptide Wu & Wilcox, 1990) . Within this region is an especially highly conserved tract (greater than 54 % identity with four members of the alphaherpesvirus family ; see Fig. 1 a) , and we Table 1 . A summary of the single-and double-aminoacid substitution mutants described in this study
I10X ts (ts K mutation) * The mutation nomenclature gives the codon co-ordinate of the mutation, then the original and substituted residues. † The background refers to the version of the bacterially expressed DNA binding domain which was used to investigate the effects of the mutation. ‡ The DNA binding phenotype is noted as follows : j, normal binding ; -, no binding ; ts, binding at 20 mC but not at 37 mC. wished to investigate by fine structure analysis whether this sequence contributed to the DNA binding or dimerization properties of the polypeptide. Since the bacterially expressed, isolated Vmw175 DNA binding domain exhibits a DNA binding specificity virtually indistinguishable from that of the intact protein , we chose to conduct a thorough mutational analysis using the convenient bacterial expression system. The expressed polypeptides span Vmw175 residues 252-523 (protein I9X) and 276-523 (protein I10X). The behaviour of these two polypeptides in gel retardation K. E. Allen and R. D. Everett K. E. Allen and R. D. Everett Gel retardation assays to determine the phenotype of the mutant DNA binding domain peptides. The identities of the mutant peptides are given above each track in the upper panel of each part, and the lower panels are arranged so that the relevant tracks of the same mutant are vertically in line. Tracks labelled control were incubated without added protein ; that marked ' -' in (c) was incubated with an extract from induced bacteria without an expression plasmid. To the right of each panel the arrow marked ' C ' indicates the protein-DNA complex, that marked ' P ' indicates the free probe, and the unlabelled arrow points to the full-length polypeptide on the Western blot. The upper panel in each case shows results after incubation at 20 mC, while that below shows the results after incubation at 37 mC. In (a-c) the lowermost panel compares the amount of DNA binding domain peptide as detected by Western blotting ; note that the slight size difference between the various proteins reflects whether the mutation is in the I9X or I10X background (see Table 1 and Methods). The amount of extract in the DNA binding reactions was adjusted according to these results. The analogous Western blot data for (d) is not shown, but the only mutant analysed in this panel which exhibited reduced DNA binding (457R/L) was expressed normally in the bacterial system (Allen, 1994) . Each gel retardation panel includes the relevant I9X or I10X positive control. Note that the order of the tracks shown in these panels does not correspond to the numerical order of the mutations shown in DNA binding assays is essentially identical  unpublished data) and they have been used interchangeably throughout this study. Mutagenesis was carried out as described in Methods, and the mutations were transferred into plasmids which enable the expression of mutant I10X or I9X polypeptides. A summary of the mutants described in this study is given in Table 1 .
Selected mutations within the highly conserved tract affect DNA binding by isolated fragments of Vmw175
Partially purified bacterial extracts containing mutant and wild-type I9X or I10X polypeptides were prepared and equivalent amounts of each polypeptide (as determined by Western blot analysis) were used in gel retardation DNA binding experiments with a probe spanning the IE-3 cap site. The results are summarized in Fig. 2 (a-d ) and Table 1 . Two of the single point mutants tested, 456R\L and 459D\Y, and one double mutant, 463\4KG\NC, were found to be DNA binding-defective at ambient temperature, while mutant 457R\L appeared to exhibit greatly reduced DNA binding activity. None of the other mutations appeared to affect DNA binding activity under the conditions used. However, since the well characterized temperature-sensitive (ts) point mutation in virus ts K lies within this same conserved region (Davison et al., 1984) , we considered it possible that some of the mutations might cause a ts defect in DNA binding. The ts phenotype of the mutant tsK Vmw175 protein has been reproduced in DNA binding studies . Accordingly, we repeated the gel retardation assay incubations at 37 mC before running the gels at room temperature. Western blot analysis demonstrated that incubation at 37 mC did not affect the stability of the DNA binding domain peptides (data not shown). The results showed that a number of the mutants bound to DNA with equal efficiency at both room temperature and 37 mC, but some bound normally at the lower but not at all at the higher temperature. These included the single mutants 449A\S, 453A\S, 457R\L and 472R\L and the double mutant 451\3AA\SS (Fig. 2) . The ts nature of the defects caused by these mutations suggests that they affect the stability of the conformation of the domain, rather than a direct interaction with DNA. The fact that so many single amino acid substitutions within this highly conserved region affect DNA binding highlights its functional importance.
Mutations within the highly conserved tract do not appear to affect dimerization of the Vmw175 DNA binding domain
The Vmw175 DNA binding domain is a dimer in solution and binds to DNA as a dimer . Mutations which affect its ability to bind to DNA could do so either directly, by affecting the residues that actually contact the DNA, or indirectly, by affecting di- K. E. Allen and R. D. Everett K. E. Allen and R. D. Everett merization or other conformational properties of the protein.
One reliable way of determining the dimerization state of a polypeptide is to determine its molecular size by gel filtration. We selected two of the binding-deficient mutant polypeptides (456R\L and 463\4KG\NC) for further purification and gel filtration chromatography, and analysed them in parallel with the relevant wild-type (dimeric) polypeptide. The results showed that both mutant proteins were eluted from gel filtration columns at the position expected of a dimer (Fig. 3) . Therefore, these mutations do not effect the dimerization state of the polypeptide. These results are in agreement with additional mutational studies identifying a putative Vmw175 dimerization motif mapping within amino acids 343-376 (Gallinari et al., 1994) .
Single amino acid substitutions within the highly conserved tract reduce DNA binding by intact Vmw175 and its ability to activate gene expression
Based on the above results, four of the mutations (453A\S, 463\4 KG\NC, 457R\L and 456 R\L) were selected for analysis in the context of the full-length Vmw175 protein. The mutations were transferred into plasmid pLI175, which contains the full-length IE-3 ORF (with a silent point mutation removing the BamHI restriction site at nucleotide 1725) under the control of the SV40 early promoter. The resultant plasmids were transfected into HeLa cells in order to investigate the DNA binding and transactivation properties of the mutant proteins. Equal quantities of extracts from transfected cells were analysed by gel retardation assays for binding to the Vmw175 IE-3 cap site probe (Fig. 4 a) . In agreement with the results using the isolated DNA binding domain polypeptides, mutants 463\4 KG\NC and 456R\L were unable to bind to DNA. Mutant 457R\L was also DNA binding-defective in the context of the whole protein, whereas it caused substantially reduced and ts DNA binding in the isolated DNA binding domain. Vmw175 mutant 453A\S bound to DNA normally in this assay ; this mutation caused a ts DNA binding defect in the bacterial system, but technical difficulties precluded attempts to test whether the DNA binding by the intact protein was also ts.
The initial DNA binding analyses using the isolated bacterially expressed DNA binding domains had been performed using normalized amounts of protein. However, it was possible that the mutations were not affecting DNA binding by the intact protein directly, but were inducing conformational changes which reduced the stability or expression of the protein in the transfected cells. Therefore, the amount of Vmw175 in the extracts was determined by Western blotting (Fig. 4 b) . All of the extracts contained detectable full-length Vmw175, but the actual amounts differed significantly. Since the data in Fig. 2 clearly indicate that mutations 463\4 KG\NC, 457R\L and 456R\L eliminate or severely reduce the DNA binding ability of the isolated DNA binding domain, it is reasonable to conclude from these results that in addition to affecting DNA binding activity, these mutations are also reducing the intrinsic stability or expression of intact Vmw175.
In addition to the DNA binding analysis, the mutant proteins were tested for their ability to transactivate the gD promoter in synergy with Vmw110 (Fig. 5) . Wild-type Vmw175 transactivated the gD promoter up to 20-fold, a Mutational analysis of HSV-1 IE protein Vmw175 Mutational analysis of HSV-1 IE protein Vmw175 Fig. 5 . Activation of gene expression from the reporter plasmid pgDCAT in transiently transfected HeLa cells. Increasing amounts of the indicated activator plasmids were transfected with 4 µg of the reporter plasmid and 4 µg of the Vmw110 expression plasmid p111, and CAT activity in whole cell extracts was determined 2 days later. The results are presented as fold-increases over the level achieved with pgDCAT and p111 and are the averages from two independent transfection experiments (i.e. a total of eight data points for each plasmid in total). The variation from the mean of the duplicate results at each plasmid concentration was less than 20 % for p175, pLI175 and pGL453A/S, and negligible for the inactive mutants. result in agreement with previous studies . The substitution mutant 453A\S caused a moderate reduction in transactivation activity. This mutation had no Everett (1988 a) . † The relative abilities of the mutant proteins to bind to the IE-3 cap site as determined from visual inspection of autoradiographs. Data from Paterson & Everett (1988 b) . ‡ Relative amounts of the mutant proteins in the nuclear extracts used in the DNA binding assays, determined by ELISA using monoclonal antibody 58S (p175 l 100). Data from Paterson & Everett (1988 b) . § The viability of recombinant viruses containing the mutant Vmw175 molecule in non-complementing BHK cells, as determined by co-transfection experiments with genomic DNA of the Vmw175 deletion mutant virus, D30EBA. ' j ' indicates that viable virus was recovered from cells harvested from the transfection at levels which varied from 1i10% to 1i10' p.f.u.\ml in different experiments. The background level, indicated by ' -', was less than 1i10# p.f.u.\ml. , Not determined. The expected restriction sites in the I9, I10 and I11 derivative viruses were confirmed by Southern blot analysis of purified virus stocks (Allen, 1994) . effect on DNA binding by full-length Vmw175 at room temperature, but caused a ts DNA binding phenotype when present in the isolated DNA binding domain (Fig. 2) . Less efficient transactivation by 453A\S may be a result of reduced functionality reflected by the ts phenotype of the bacterially expressed DNA binding domain. The substitution mutants 463\4KG\NC, 456R\L and 457R\L eliminated transactivation by Vmw175. As discussed above, Western blot analysis demonstrated that these mutant proteins were expressed at reduced levels in transfected cells. However, these plasmids were unable to stimulate gene expression even at input doses 80 times that which gave a 5-10-fold activation with plasmids expressing wild-type Vmw175. Again, whilst the destabilizing effects of these mutations must be considered, it is reasonable to conclude that the amino acid alterations are eliminating the transactivation ability of the protein that is being expressed.
Mutations within the DNA binding domain of Vmw175 are incompatible with virus replication
As well as the single point mutations described above, a large number of four-amino-acid insertion mutations were available from a previous study (Patterson & Everett, 1988 which could be used to analyse whether mutations within the Vmw175 DNA binding domain were compatible with virus growth. The strategy adopted was to co-transfect genomic DNA of virus mutant D30EBA (which has a large deletion within both copies of the IE-3 coding region ; with linearized plasmid DNA carrying mutant forms of the IE-3 coding sequence. Recombination between the plasmid and viral DNAs would yield viable virus in non-complementing cells only if the mutation was not deleterious for Vmw175 function. Cotransfections of D30EBA with pUC19 DNA showed that the background level of competent virus in these experiments was zero.
The pI series of plasmids contain four-amino-acid insertion mutations throughout the IE-3 ORF. These mutations had previously been assayed for their DNA binding and transactivation properties in transient transfection and gel retardation analyses (Paterson & Everett, 1988 a, b) . Plasmids containing mutations within the Vmw175 DNA binding domain (pI9-pI20) were tested for their ability to support HSV-1 replication in tissue culture. The results, summarized in Table  2 , clearly show that none of the mutant plasmids which expressed Vmw175 proteins with reduced DNA binding activity was able to generate viable virus. Similar results were obtained when the DNA binding-deficient single-amino-acid substitution mutant plasmids were tested (Table 3 ). The only mutation of those tested which was compatible with virus growth was 453A\S, which caused a ts phenotype when present in the isolated bacterially expressed DNA binding domain polypeptide (Fig. 2) . In the context of the intact protein there was no effect of this mutation on DNA binding at room temperature (Fig. 4) , but the mutation moderately reduced the ability of Vmw175 to activate gene expression in transfected cells (Fig. 5) . The virus recovery assay used here is insufficiently sensitive to detect any small or moderate growth defect which may be caused by the 453A\S mutation.
Discussion
Regions of Vmw175 which contribute to DNA binding activity
This paper shows that the highly conserved tract towards the C-terminal end of the Vmw175 DNA binding domain is crucially important for the functions of the protein. Amino acid substitutions affecting 15 of the 44 residues in this region were constructed in the background of the isolated DNA binding domain. Of these, eight caused either a total or ts defect in DNA binding, and a selection of these DNA binding-defective mutants were found to be unable to activate gene expression or support virus growth. Interestingly, five of the seven mutations that do not affect binding are at positions that are not completely conserved between the HSV-1, varicella-zoster virus (VZV), pseudorabies virus (PRV) and equid herpesvirus type 1 (EHV-1) proteins, while four of the five ts mutations and all the binding-negative mutations affect totally conserved residues ( Fig. 1 and Table 1 ). This is reminiscent of the locations of ts lesions elsewhere in Vmw175, all of which affect completely conserved residues .
A previous study has found that a different highly conserved motif, with some similarity to the homeodomain recognition helix, is very important for DNA binding by the related VZV140k domain . This sequence comprises Vmw175 codons 390-396 and VZV140k codons 544-550. Thus single residue substitutions in two distinct regions of these related domains can eliminate DNA binding of the protein. It is possible that the DNA binding domain comprises more than one motif that contacts DNA. Indeed, there are several examples of DNA binding proteins that do exactly this, for example the Oct-1 transcription factor (Verrijzer et al., 1990 (Verrijzer et al., , 1992 . We note that the recognition sequence of the Vmw175 DNA binding domain is bi-partite and non-palindromic, as is the case with the Oct-1 recognition sequence. Alternatively, it is possible that the highly conserved tract mutated in this paper plays a part in maintaining the stability of the DNA binding domain, rather than contacting the DNA directly. This possibility is supported by the observation that several of the point mutations affected the stability of full-length Vmw175.
The role of DNA binding in Vmw175 function
The objects of this study were to investigate the role of the highly conserved tract in Vmw175 function, and to test the correlation between the loss of DNA binding ability and the other functions of the protein. As explained in the Introduction, the importance of this question arises from the observation that an obligate role for Vmw175 DNA binding sites in CJCA promoter activation has not been demonstrated, while one mutant (pri12) has been found which has a greatly diminished ability to bind to a specific recognition sequence yet supports virus replication . On the other hand, a large number of DNA binding-negative Vmw175 mutants which are unable to activate gene expression or support virus growth have been described (DeLuca & Schaffer, 1988 ; Paterson & Everett, 1988 b ; Shepard et al., 1989 ; Imbalzano et al., 1990 ; Shepard & DeLuca, 1991 b ; this study), and similar conclusions have resulted from studies with the homologous VZV protein . How can the observation with pri12 be reconciled with these other studies? It may be pertinent that the pri12 mutation did not eliminate the ability of the purified mutant Vmw175 to bind nonspecifically to DNA , and a bacterially expressed Vmw175 DNA binding domain containing the pri12 mutation was able to bind normally to DNA at room temperature (Allen, 1994) . In addition, further analysis has illustrated that the ri12 protein can interact with DNA in the presence of basal transcription factors (Smith et al., 1993) . Therefore, the ri12 molecule is not completely incapable of interaction with DNA. It is possible that in the infected cell the pri12 protein interacts normally with DNA in association with the components of the basal transcription machinery which have been implicated in the mechanism of transactivation by Vmw175 (Carrozza & DeLuca, 1996, and references therein) .
Using a variety of insertion and substitution mutants in Vmw175, this study illustrates that mutations which disrupt the in vitro properties of Vmw175 are incapable of complementing the deletion HSV-1 mutant D30EBA in tissue culture. This suggests that the conclusions drawn from previous in vitro assays are valid, and give a close approximation to the actual in vivo activity of the molecule. From the results presented here, it can be concluded that the DNA binding domain of Vmw175 is extremely important, if not essential, for its full transactivation activity in vivo, and that a small conserved tract within the C-terminal portion of this domain is essential for its activity both in vitro and in vivo.
